Search

everythinglearnresearchcommunity

for

Search:↓

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The books were useful but had some areas needing improvement.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Elagolix did not effectively treat polycystic ovary syndrome.

RCS-01 is safe and may help rejuvenate aging skin.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

The new method improves accuracy in segmenting scalp tissue layers.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

New method uses hair follicle cells to estimate human body clock phase, potentially improving sleep disorder diagnosis.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The hydrogel dressing speeds up and improves diabetic wound healing.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.